PT841344E - 1-(2-desoxi-2-fluoro-4-tio-beta-d-arabinofuranosil) citosinas - Google Patents
1-(2-desoxi-2-fluoro-4-tio-beta-d-arabinofuranosil) citosinasInfo
- Publication number
- PT841344E PT841344E PT97916633T PT97916633T PT841344E PT 841344 E PT841344 E PT 841344E PT 97916633 T PT97916633 T PT 97916633T PT 97916633 T PT97916633 T PT 97916633T PT 841344 E PT841344 E PT 841344E
- Authority
- PT
- Portugal
- Prior art keywords
- arabinofuranosyl
- cytosines
- thio
- fluoro
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11196896 | 1996-04-09 | ||
| JP21508296 | 1996-07-26 | ||
| JP27863196 | 1996-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT841344E true PT841344E (pt) | 2003-02-28 |
Family
ID=27312140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97916633T PT841344E (pt) | 1996-04-09 | 1997-04-09 | 1-(2-desoxi-2-fluoro-4-tio-beta-d-arabinofuranosil) citosinas |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6147058A (pt) |
| EP (1) | EP0841344B1 (pt) |
| JP (1) | JP3657008B2 (pt) |
| AT (1) | ATE224909T1 (pt) |
| CA (1) | CA2224155C (pt) |
| DE (1) | DE69715774T2 (pt) |
| DK (1) | DK0841344T3 (pt) |
| ES (1) | ES2182061T3 (pt) |
| PT (1) | PT841344E (pt) |
| WO (1) | WO1997038001A1 (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7138384B1 (en) | 1997-08-29 | 2006-11-21 | The Regents Of The University Of California | Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
| MXPA00008348A (es) * | 1998-02-25 | 2005-07-15 | Univ Emory | 2-fluronucleosidos. |
| JP5379347B2 (ja) * | 2003-09-18 | 2013-12-25 | アイシス ファーマシューティカルズ， インコーポレーテッド | ４’−チオヌクレオシドおよびオリゴマー化合物 |
| US7524831B2 (en) * | 2005-03-02 | 2009-04-28 | Schering Corporation | Treatments for Flaviviridae virus infection |
| EP2388257A1 (en) * | 2010-05-20 | 2011-11-23 | LibraMedicina, Inc. | Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-ß-D-arabinofuranoses |
| AU2010331367B2 (en) | 2009-12-18 | 2017-04-20 | Libramedicina, Inc. | Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranoses |
| SG10201603288XA (en) | 2012-03-28 | 2016-05-30 | Fujifilm Corp | Salt Of 1-(2-Deoxy-2-Fluoro-4-Thio-beta-D-Arabinofuranosyl)Cytosine |
| PL2883866T3 (pl) | 2012-08-13 | 2019-07-31 | Fujifilm Corporation | Produkt pośredni do syntezy 1-(2-deoksy-2-fluoro-4-tio-beta-d-arabinofuranosylo)cytozyny, produkt pośredni do syntezy tionukleozydu i sposoby otrzymywania tych produktów pośrednich |
| WO2014197578A1 (en) * | 2013-06-05 | 2014-12-11 | Idenix Pharmaceuticals, Inc. | 1',4'-thio nucleosides for the treatment of hcv |
| JP6351107B2 (ja) * | 2014-02-18 | 2018-07-04 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
| WO2015125781A1 (ja) | 2014-02-18 | 2015-08-27 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
| JP6204223B2 (ja) | 2014-02-19 | 2017-09-27 | 富士フイルム株式会社 | チオピラノース化合物等の製造方法 |
| TWI678373B (zh) * | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| EA034375B1 (ru) * | 2015-04-03 | 2020-01-31 | Сычуань Кэлунь-Байотек Байофармасьютикал Ко., Лтд. | Новое соединение 4'-тионуклеозида, а также способ его получения, его фармацевтическая композиция и применение |
| JP6450356B2 (ja) * | 2016-02-29 | 2019-01-09 | 富士フイルム株式会社 | 液状医薬製剤 |
| MX2019002430A (es) * | 2016-08-31 | 2019-07-04 | Fujifilm Corp | Agente antitumoral, mejorador del efecto antitumoral, y kit antitumoral. |
| JP2020502043A (ja) | 2016-12-22 | 2020-01-23 | シチュアン ケルン−バイオテック バイオファーマシューティカル カンパニー リミテッド | ４’−チオ−２’−フルオロヌクレオシドホスファミド化合物の固体形態及びそのための調製方法及びその使用 |
| US11266674B2 (en) | 2017-09-01 | 2022-03-08 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Pharmaceutical composition for tumor treatment or prevention, method, and use thereof |
| WO2019146129A1 (ja) * | 2018-01-29 | 2019-08-01 | 富士フイルム株式会社 | イソクエン酸デヒドロゲナーゼ変異を有する腫瘍に対する医薬組成物および抗腫瘍剤ならびにその利用 |
| TW201932119A (zh) | 2018-01-29 | 2019-08-16 | 日商富士軟片股份有限公司 | 膽道癌用抗腫瘤劑和膽道癌的處理方法 |
| TW202000207A (zh) * | 2018-02-26 | 2020-01-01 | 日商富士軟片股份有限公司 | 膀胱癌用抗腫瘤劑及膀胱癌的處置方法 |
| CA3093794C (en) * | 2018-03-13 | 2023-03-14 | Fujifilm Corporation | Antitumor enhancer agent comprising 1-(2-deoxy-2-fluoro-4-thio-b-d-arabinofuranosyl)cytosine and an antitumor platinum complex |
| AU2019349424B2 (en) * | 2018-09-25 | 2024-04-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof |
| WO2020108343A1 (zh) * | 2018-11-28 | 2020-06-04 | 四川科伦博泰生物医药股份有限公司 | 以4'-硫代核苷类化合物为活性成分的口服药物组合物、其制备方法及其用途 |
| US20220281910A1 (en) * | 2019-07-30 | 2022-09-08 | Pinotbio, Inc. | Dinucleotide compounds for treating cancers and medical uses thereof |
| KR20240028451A (ko) | 2021-07-29 | 2024-03-05 | 후지필름 가부시키가이샤 | Bap1 및 pbrm1 중 적어도 하나의 기능 저하를 갖는 종양에 대한 의약 조성물 및 항종양제 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE74701B1 (en) * | 1989-10-04 | 1997-07-30 | Univ Birmingham | Further antiviral pyrimidine nucleosides |
| EP0770621A4 (en) * | 1994-07-12 | 1998-01-28 | Yamasa Corp | 2'-DESOXY-2 '- (METHYLIDENE SUBSTITUTED OR NON-SUBSTITUTED) -4'-THIONUCLEOSIDE |
| JPH0853490A (ja) * | 1994-08-09 | 1996-02-27 | Yamasa Shoyu Co Ltd | ２’−デオキシ−２’，２’−ジハロゲノ−４’−チオヌクレオシド |
-
1997
- 1997-04-09 AT AT97916633T patent/ATE224909T1/de active
- 1997-04-09 ES ES97916633T patent/ES2182061T3/es not_active Expired - Lifetime
- 1997-04-09 DK DK97916633T patent/DK0841344T3/da active
- 1997-04-09 DE DE69715774T patent/DE69715774T2/de not_active Expired - Lifetime
- 1997-04-09 CA CA002224155A patent/CA2224155C/en not_active Expired - Lifetime
- 1997-04-09 JP JP52839997A patent/JP3657008B2/ja not_active Expired - Lifetime
- 1997-04-09 US US08/973,529 patent/US6147058A/en not_active Expired - Lifetime
- 1997-04-09 EP EP97916633A patent/EP0841344B1/en not_active Expired - Lifetime
- 1997-04-09 PT PT97916633T patent/PT841344E/pt unknown
- 1997-04-09 WO PCT/JP1997/001206 patent/WO1997038001A1/ja active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE69715774T2 (de) | 2003-05-15 |
| ATE224909T1 (de) | 2002-10-15 |
| DE69715774D1 (de) | 2002-10-31 |
| CA2224155A1 (en) | 1997-10-16 |
| ES2182061T3 (es) | 2003-03-01 |
| JP3657008B2 (ja) | 2005-06-08 |
| EP0841344B1 (en) | 2002-09-25 |
| EP0841344A1 (en) | 1998-05-13 |
| EP0841344A4 (pt) | 1998-05-13 |
| CA2224155C (en) | 2004-10-26 |
| WO1997038001A1 (fr) | 1997-10-16 |
| DK0841344T3 (da) | 2002-12-23 |
| US6147058A (en) | 2000-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0841344T3 (da) | 1-(2-Desoxy-2-fluor-4-thio-Beta-D-arabinofuranosyl)cytosiner | |
| ZA200309887B (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
| AU5211686A (en) | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | |
| ATE201195T1 (de) | Tricyclische verbindungen | |
| SI1385518T1 (sl) | Benzimidazolonske spojine | |
| EP0807630A4 (en) | HETEROCYCLIC CONNECTIONS | |
| EP0714900A3 (de) | Alkylhydrogenchlorsilane, Verfahren zu deren Herstellung und deren Verwendung | |
| BG103778A (en) | Process for preparing pyrazole derivatives | |
| MXPA00012863A (es) | Proceso para la preparacion de 3-aril-benzofuranonas. | |
| FI955954A0 (fi) | Thiolyhdisteitä | |
| GB0020613D0 (en) | Catalysts | |
| GR3029836T3 (en) | Process for producing n-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same | |
| ATE223414T1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
| EP0747350A4 (en) | PROCESS FOR THE MANUFACTURE OF BIS (4-ALKYLTHIOPHENYLE) BISULFIDE | |
| DE69706950D1 (de) | Furoindolizine | |
| EP0978281A4 (en) | EYE DROPS | |
| EP0551632A3 (en) | Process for the preparation of halogenoanthranilic acid | |
| AU7020996A (en) | UCK14 compounds | |
| ATE206699T1 (de) | Uch-15-verbindungen | |
| BR0016521B1 (pt) | processo para produÇço de 2-nitroguanidinas 1,3-dissubstituÍdas. | |
| ES2194745T3 (es) | Procedimiento para la obtencion de 4,6-dicloropirimidi-na. | |
| FI904981A0 (fi) | Nya inosin/guanosinderivat. | |
| ATE244217T1 (de) | Herstellung von beta-mehtylcarbapenem- zwischenprodukten | |
| ES2164345T3 (es) | Procedimiento de produccion de compuestos 3-norcefema. |